Abstract: M.2 Universal Flash Storage (UFS) and combined UFS/PCIe cards are described herein. In one example, the same M.2 interface is reused on the main board of laptop for supporting both PCIe SSD and UFS storage. One M.2 socket can accommodate a UFS Add-In-Card, a combined PCIe/UFS card, and/or a PCIe SSD. In one example, an M.2 UFS card includes a printed circuit board (PCB), an edge to be received by an M.2 connector, conductive contacts at the edge to couple with contacts of the M.2 connector, a UFS storage device, and UFS signal lines between the conductive contacts and the UFS storage device.

Abstract: A computing system includes a display and a processor coupled to the display. The processor is configured to: identify a particular area in a representation of a geologic formation displayed on the display; control the display to display a grid block to encompass the particular area, without reference to one or more underlying grid boundaries; control the display to display a plurality of buffer grid blocks adjacent to the grid block; and refine a resolution of the grid block. Controlling the display to display the grid block without reference to the one or more underlying grid boundaries allows the resolution of the grid block to be refined without restriction by the one or more underlying grid boundaries.

Abstract: The present invention disclosed compound 2-methyl-5-imino-benzo[d][1,3]oxazin[5-b]pyrazole and preparation method and uses thereof. The compound 2-methyl-5-imino-benzo[d][1,3]oxazin[5-b]pyrazole of the present invention has the following structure of formula (II), wherein the compound or pharmaceutically acceptable salts thereof can be used for preparing the drugs for treatment or prevention of cardiovascular diseases.

Abstract: The present invention disclosed compound 2-methyl-5-imino-benzo[d][1,3]oxazin[5-b]pyrazole and preparation method and uses thereof. The compound 2-methyl-5-imino-benzo[d][1,3]oxazin[5-b]pyrazole of the present invention has the following structure of formula (II), wherein the compound or pharmaceutically acceptable salts thereof can be used for preparing the drugs for treatment or prevention of cardiovascular diseases.